Longboard Pharmaceuticals Stock Analysis

Longboard Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.25. Longboard Pharmaceuticals had not issued any dividends in recent years. Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people. To find out more about Longboard Pharmaceuticals contact Kevin Lind at 858 789 9283 or learn more at https://www.longboardpharma.com.

Longboard Pharmaceuticals Investment Alerts

Longboard Pharmaceuticals Upcoming and Recent Events

Longboard Largest EPS Surprises

View All Earnings Estimates

Longboard Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Longboard Stock Institutional Investors

Note, although Longboard Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Longboard Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.34 B.

Longboard Profitablity

Management Efficiency

Longboard Pharmaceuticals has return on total asset (ROA) of (0.3072) % which means that it has lost $0.3072 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4666) %, meaning that it created substantial loss on money invested by shareholders. Longboard Pharmaceuticals' management efficiency ratios could be used to measure how well Longboard Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.13. The current Return On Capital Employed is estimated to decrease to -1.46. As of now, Longboard Pharmaceuticals' Total Current Assets are increasing as compared to previous years.

Technical Drivers

As of the 4th of December, Longboard Pharmaceuticals secures the Downside Deviation of 4.01, risk adjusted performance of 0.1134, and Mean Deviation of 3.25. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Longboard Pharmaceuticals, as well as the relationship between them.

Longboard Pharmaceuticals Price Movement Analysis

Longboard Pharmaceuticals Insider Trading Activities

Longboard Pharmaceuticals Outstanding Bonds

Longboard Pharmaceuticals Predictive Daily Indicators

Longboard Pharmaceuticals Corporate Filings

Longboard Pharmaceuticals Forecast Models

Longboard Pharmaceuticals' time-series forecasting models are one of many Longboard Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Longboard Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Longboard Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Longboard shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Longboard Pharmaceuticals. By using and applying Longboard Stock analysis, traders can create a robust methodology for identifying Longboard entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Longboard analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Longboard analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Longboard Pharmaceuticals stock analysis indicators help investors evaluate how Longboard Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Longboard Pharmaceuticals shares will generate the highest return on investment. By understating and applying Longboard Pharmaceuticals stock analysis, traders can identify Longboard Pharmaceuticals position entry and exit signals to maximize returns.

When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.